Table 4.
Results of univariate and multivariate logistic regression analysis to compare the association between the presence of metastatic accumulation and clinical factors
| Univariate analysis | Multivariate analysis | |||
| Factors | OR
95% CI |
P value | OR
95% CI |
P value |
|
Age > 45 years
(vs. ≤ 45 years) |
0.883
0.514–1.516 |
0.651 | ||
|
Male
(vs. Female) |
1.459
0.858–2.481 |
0.163 | ||
|
rhTSH
(vs. Withdrawal of thyroid hormone) |
0.801
0.407–1.575 |
0.520 | ||
|
Dose of RAI > 1,110 MBq
(vs. 1,110 MBq) |
1.349
0.682–2.670 |
0.390 | ||
|
Period from total thyroidectomy to ablation > 180 days
(vs. ≤ 180 days) |
0.872
0.520–1.463 |
0.605 | ||
|
pT3-4
(vs. pT1-2) |
0.815
0.437–1.520 |
0.520 | ||
|
pN1
(vs. N0) |
6.742
0.875–51.917 |
0.067 | 6.264
0.808–48.564 |
0.079 |
|
TSH > 30 μU/mL
(vs. ≤ 30 μU/mL) |
0.597
0.098–3.639 |
0.576 | ||
|
Tg > 1.5 ng/ml
(vs. ≤ 1.5 ng/ml) |
1.985
1.055–3.733 |
0.033 | 1.929
1.013–3.672 |
0.046 |
|
Tg-Ab > 100 IU/mL
(vs. ≤ 100 IU/ml) |
0.564
0.205–1.548 |
0.266 | ||
OR: odds ratio, 95%CI: 95% confidence interval, RAI: Radioactive iodine, rhTSH: Recombinant human thyroid stimulating hormone, Tg: Thyroglobulin, Tg-Ab: Anti-thyroglobulin antibody, TSH: Thyroid stimulating hormone.